A Critical Eye on Progress: FDA Official Questions uniQure's Huntington's Trial Comparisons

A Major Setback: FDA Halts uniQure's Huntington's Gene Therapy Trial

Biotech Sensation: uniQure's Huntington's Breakthrough Fuels Historic Stock Surge

A New Horizon of Hope: uniQure's AMT-130 Shines with Positive 3-Year Data in Huntington's Disease

A Beacon of Hope: uniQure's AMT-130 Gene Therapy Shines in Huntington's Disease Trial